ASP Isotopes Inc. Common Stock (ASPI) is a Materials stock trading at $3.98 (as of 2026-08-21), with a market capitalization of $610.17M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
ASP Isotopes Inc. produces and distributes isotopes through activities that include marketing and sales. Its portfolio includes Molybdenum-100, Carbon-14, Silicon-28, and Uranium-235, with applications in medical use cases and the carbon-free energy industry.
ASP Isotopes develops and sells specialty isotopes, including Molybdenum-100, Carbon-14, Silicon-28, and Uranium-235, for medical and carbon-free energy uses, earning money through the production, distribution, marketing, and sale of these isotopes.
The company is pre-commercial, so near-term results appear to hinge on getting isotope production and commercialization to generate revenue, because currently revenue is 0.0B while operating losses are very large.
| Radio | $0.0B |
| Skyline | $0.0B |
Business quality (Weak): Transparent business description, but the latest quarter shows 0.0B revenue and a very large operating loss, which limits how much investors can infer from reported financial performance.
| Price | $3.98 |
| Market Cap | $610.17M |
| Price / Book | 2.22 |
| Price / Sales | 39.65 |
| FCF Yield | -15.4% |
| Revenue (TTM) | $23.85M |
| Net Margin | -670.2% |
| Revenue Growth (YoY) | 475.5% |
| EPS Growth (YoY) | 234.9% |
| FCF Growth (YoY) | 79.9% |
| Altman Z-Score | 1.16 (distress) |
| Piotroski F-Score | 4/9 (moderate) |
| Sector P/E (Materials) | 25.9 |
| Industry P/E (Chemicals) | 31.1 |
| Top Institutional Holder | BlackRock, Inc. ($36.81M) |
| Institutional Holders Tracked | 10 |
| Sector | Materials |
| Industry | Chemicals |
| CEO | Paul Elliot Mann |
| Employees | 136 |
| Country | US |
| IPO Date | 2022-11-10 |
Data as of 2026-08-21.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.